FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds possessing high activity targeted on modulating NMDA-receptor activity and using the same for treating diseases and disorders, such as learning disorder, cognitive disorders and analgesia, and particularly for relieving and/or eliminating neuropathic pain.
EFFECT: producing compounds possessing high activity targeted on modulating NMDA-receptor activity.
9 cl, 13 dwg, 2 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NMDA RECEPTOR MODULATORS AND USING THEM | 2009 |
|
RU2515615C2 |
| COMBINATIONS OF COMPOUNDS MODULATING THE NMDA RECEPTOR | 2015 |
|
RU2721948C2 |
| METHODS OF TREATING OR RELIEVING MIGRAINE | 2015 |
|
RU2721401C2 |
| USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
| GUANIDINE-CONTAINING COMPOUNDS APPLICABLE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2008 |
|
RU2480458C2 |
| AGENTS AGAINST FEEBLE-MINDEDNESS COMPRISING DERIVATIVES OF 2-ARYL-8-OXODIHYDROPURINE AS ACTIVE COMPONENT | 2001 |
|
RU2277096C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| PTERIDINES EFFECTIVE AS HCV INHIBITORS AND METHODS FOR PRODUCING PTERIDINES | 2006 |
|
RU2447074C2 |
| NOVEL LIGANDS OF ESTROGEN RECEPTORS | 2009 |
|
RU2492164C2 |
| HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES | 2005 |
|
RU2405778C2 |
